BS
AGN

Bow Street’s Allergan plc AGN Stock Holding History

Bow Street’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-23,351
Closed -$6.95M – 36
2015
Q1 		$6.95M Buy
23,351
+13,834
+145% +$3.94M 2.75% 14
2014
Q4 		$2.45M Sell
9,517
-15,178
-61% -$3.79M 0.87% 26
2014
Q3 		$5.96M Sell
24,695
-34,517
-58% -$7.72M 2.12% 20
2014
Q2 		$13.2M Buy
59,212
+12,668
+27% +$2.62M 4.41% 7
2014
Q1 		$9.58M Sell
46,544
-7,000
-13% -$1.39M 4.57% 8
2013
Q4 		$8.99M Buy
+53,544
New +$8.37M 4.19% 10

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bow Street's AGN Position: Q2 2015 in Review

Bow Street sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 23,351 shares — an estimated $6.95M sold.

Bow Street first reported a position in AGN in Q4 2013 and held it in 6 quarters. The position peaked at $13.2M in Q2 2014. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Bow Street reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • Bow Street sold 23,351 Allergan plc shares in Q2 2015, an estimated $6.95M.
  • Bow Street first reported a position in Allergan plc in Q4 2013 and held it in 6 quarters.
  • Bow Street's Allergan plc position peaked at $13.2M in Q2 2014.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Bow Street's 13F filing for Q2 2015, filed 13 Aug 2015.